The Lil Mixins lawsuit that shows up in search results is not actually a lawsuit against Lil Mixins. The company has not been sued. The class action people are looking for was filed in October 2022 against a competitor, Before Brands, which made SpoonfulONE. Lil Mixins gets pulled into the conversation because it positioned itself as the available alternative after SpoonfulONE suspended U.S. sales in the wake of that case.
What the SpoonfulONE Class Action Claimed
On October 27, 2022, consumers filed Harris et al. v. BEFORE Brands, Inc. dba SpoonfulONE (Case No. 3:22-cv-06577-AGT) in the U.S. District Court for the Northern District of California. Named plaintiffs came from Minnesota, New York, Texas, Alabama, and California. The complaint alleged fifteen violations of federal and state law with estimated damages above $5 million.1Food Business News. Before Brands Sued for Mislabeled Baby Food
The central claim was that SpoonfulONE Puffs, Crunchy Puffs, and Oat Crackers did not contain the 30 milligrams of allergenic protein from 16 foods advertised on the packaging. Plaintiffs pointed to a 2022 study in The Journal of Allergy and Clinical Immunology: In Practice by Stephanie Filep and Martin Chapman, which analyzed commercial early allergen introduction foods and reported that mixed-blend products like puffs and crackers contained very low allergen levels, often under 10 micrograms per gram, with some allergens undetectable.2American Academy of Allergy, Asthma & Immunology. Allergen Content in Early Introduction Foods The research found no detectable peanut protein in SpoonfulONE Puffs, and Oat Crackers contained less than 1 milligram each of peanut, milk, and egg protein.1Food Business News. Before Brands Sued for Mislabeled Baby Food
The plaintiffs also argued that even the advertised 30 milligrams would be too little to promote oral tolerance. They cited the 2015 LEAP study, which found that six grams of peanut protein per week reduced peanut allergy prevalence by about 70 to 80 percent in high-risk infants. Six grams is roughly 200 times the 30-milligram serving SpoonfulONE claimed.3SnackSafely. Class Action Lawsuit Against SpoonfulONE Alleges Products Contain Insufficient Quantities of Proteins
Beyond the dose question, the complaint accused Before Brands of grounding its safety and efficacy claims on a white paper posted to its own website rather than independent peer-reviewed research. It called the marketing “extraordinarily dangerous,” arguing it gave parents a “false sense of security” and could cause them to miss the critical window for genuine allergy prevention.1Food Business News. Before Brands Sued for Mislabeled Baby Food
Regulatory Problems Before the Lawsuit
SpoonfulONE had already drawn regulatory attention on two continents before the class action was filed.
In October 2020, the FDA sent Before Brands a warning letter over SpoonfulONE Puffs (Strawberry). The agency concluded the product was being marketed as an unapproved new drug because its labels and website made claims about preventing food allergies. It found the product was also misbranded for making unauthorized health claims, since health claims are generally prohibited for products intended for infants under two. The letter flagged additional labeling issues, including the vague collective term “foundational food blend” in the ingredient list, and warned that failure to correct the problems could result in seizure or injunction.4FDA. Warning Letter to Before Brands Inc.
In April 2021, a group of British allergy organizations, including the British Society for Allergy and Clinical Immunology, the British Dietetic Association, Allergy UK, and the Anaphylaxis Campaign, pressed Nestlé Health Science to halt SpoonfulONE’s UK rollout. The groups raised “significant concerns” about the milligram-level allergen quantities and the way the product was marketed as capable of reducing food allergy development. Nestlé, which held exclusive licensing rights outside the U.S., suspended the UK launch on April 19, 2021, and took down the associated website.5BSACI. Nestle Respond to Our Concerns Over SpoonfulONE
SpoonfulONE Pulled Out of the U.S. Market
Less than two months after the class action was filed, Before Brands announced on December 9, 2022 that it would pause U.S. sales of SpoonfulONE indefinitely. The company framed the move as a business decision, saying “demand for SpoonfulONE is higher in international markets” and maintaining that the products had no safety or quality concerns. Sales would continue abroad, and existing inventory at retailers including Target, Walgreens, H-E-B, and Wegmans would remain available only until sold through. Industry observers considered it unlikely SpoonfulONE would return to the U.S. market before the litigation was resolved.6SnackSafely. SpoonfulONE Suspends US Sales After Announcement of Class Action Lawsuit
That exit is the reason searches for a “Lil Mixins lawsuit” started appearing. With SpoonfulONE gone, parents looking for early allergen introduction products found Lil Mixins, and the two brands became linked in coverage of the case even though only one of them was a defendant.
Why Lil Mixins Is Not the Same Product
Lil Mixins and SpoonfulONE operated in the same category but took different approaches. SpoonfulONE sold a multi-allergen blend containing trace amounts of 16 allergenic proteins in a single serving, with the advertised 30 milligrams divided across all of them. Lil Mixins sells single-ingredient powders, one allergen category at a time: peanut, tree nuts, or baked egg. Its peanut powder delivers two grams of peanut protein per serving, which the company says matches the dose used in the LEAP study.7Lil Mixins. SpoonfulONE Alternative That is roughly 67 times the per-allergen amount SpoonfulONE advertised, and far more than independent testing found SpoonfulONE products actually contained.
Founder Meenal Lele has also been careful about what the company says its products do. In interviews, she has said Lil Mixins does not claim to prevent allergies but aims to make early allergen introduction “simple” and “affordable” for parents following pediatric guidelines.8Healio. Experts Wary of At-Home Food Allergy Products That framing matters, because the SpoonfulONE case turned largely on prevention claims the FDA had already flagged as unauthorized for infant products.
One boundary worth naming: the broader skepticism some pediatric allergists have voiced about commercial allergen introduction kits applies to the whole product category, not to any specific brand. Dr. David Stukus, a pediatric allergist, has said such kits “are not a necessity by any means and are very costly compared with readily available forms of peanut.”8Healio. Experts Wary of At-Home Food Allergy Products That is a general critique of the market, not an allegation against Lil Mixins, and it is not part of any lawsuit.